GlassScriptPhysician profile
Amanda C Vanderclay
NPI 1841414877
$3,095.49
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $433 · 2020: $139 · 2022: $330 · 2023: $644 · 2024: $1,550.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $1,500 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $500 · Food and Beverage: $194.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $1,500.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $500.00 |
| Food and Beverage | $194.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,686.65 | 2019-2024 | Da Vinci Sp, Da Vinci Surgical System |
| Astrazeneca Pharmaceuticals LP | $110.17 | 2022 | |
| Colorado Therapeutics LLC | $67.55 | 2020 | |
| Tela Bio, INC. | $62.75 | 2019 | |
| Becton, Dickinson and Company | $52.59 | 2023-2024 | Phasix Mesh |
| Zimmer Biomet Holdings, INC. | $41.61 | 2019 | |
| Innocoll Pharmaceuticals Limited | $23.77 | 2022 | |
| Kci USA, INC. | $18.75 | 2019 | |
| Next Science LLC | $16.25 | 2023 | Blastx, Xperience, Surgx |
| Boston Scientific Corporation | $15.40 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Vanderclay listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.